Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 24 | Israel Biotech Fund I | Warrants Common Stock | Option exercise | Acquire M | Yes | No | 0.4 | 2,250,000 | 900.00 k | 13,462,500 |
1 Mar 24 | Israel Biotech Fund I | Warrants Common Stock | Option exercise | Acquire M | Yes | No | 0.4 | 2,250,000 | 900.00 k | 7,837,500 |
1 Mar 24 | Israel Biotech Fund I | Convertible Promissory Note Common Stock | Option exercise | Acquire M | Yes | No | 0.4 | 1,500,000 | 600.00 k | 11,212,500 |
1 Mar 24 | Israel Biotech Fund I | Convertible Promissory Note Common Stock | Option exercise | Acquire M | Yes | No | 0.4 | 1,500,000 | 600.00 k | 5,587,500 |
1 Mar 24 | Israel Biotech Fund I | Rights Common Stock | Option exercise | Dispose M | Yes | No | 0.4 | 3,750,000 | 1.50 mm | 9,712,500 |
1 Mar 24 | Israel Biotech Fund I | Rights Common Stock | Option exercise | Dispose M | Yes | No | 0.4 | 3,750,000 | 1.50 mm | 4,087,500 |
7 Feb 24 | Israel Biotech Fund I | Common Stock, par value $0.001 per share | Payment of exercise | Dispose F | Yes | No | 1.2465 | 2,586,905 | 3.22 mm | 25,130,903 |
7 Feb 24 | Israel Biotech Fund I | Common Stock, par value $0.001 per share | Option exercise | Acquire M | Yes | No | 0.4 | 8,062,500 | 3.23 mm | 27,717,808 |
7 Feb 24 | Israel Biotech Fund I | Common Stock, par value $0.001 per share | Payment of exercise | Dispose F | Yes | No | 1.2465 | 2,707,581 | 3.37 mm | 20,661,639 |
7 Feb 24 | Israel Biotech Fund I | Common Stock, par value $0.001 per share | Option exercise | Acquire M | Yes | No | 0.4 | 8,437,500 | 3.38 mm | 23,369,220 |